Managing Agitation in the ED
December 18th, 2009 at 4:54 pm by NickKudos to Dan for his thoughtful analysis of three papers highlighting aspects of agitation management in the emergency department.
Take-home points from Journal Club this week:
* 5mg of midazolam (versed) was significantly faster at causing sedation in violently agitated patients at a large academic ED, compared to 5mg of haldol and 2mg of lorazepam (ativan). Patients getting midazolam also had significantly faster times to recover from sedation, also the least incidence of sedation failure.
* Droperidol has an FDA black box warning for QT prolongation leading to torsades de pointes and death. While the association between droperidol use and QT prolongation is clear, the risk of sudden cardiac death as caused by droperidol is much less clear. Many centers still use droperidol to good effect; an ECG after administration and prior to discharge is strongly recommended (and, if possible, prior to use).
* In treating behavioral emergencies, the accepted and endorsed practice in this country is to confront the violent or uncooperative patient with a ‘show of force’ to obtain consent, and if that fails, forcible medication ensues. Covert administration of meds, while maybe expedient or supported by the patient’s family, threatens the therapeutic alliance and exposes the institution to liability and the practitioner to claims of criminal battery. There exists an opportunity for further study and policymaking, both within our institution and beyond.
An in-depth discuss of the three papers awaits you, below.
Posted in Post-Conference Letter, Psychiatry, Arrhythmias, Journal Club, Blog | No Comments »
